Yinfeng Guo Selected Research

9,10-phenanthrenequinone

6/2022

Synthesis of dihydrofuran-3-one and 9,10-phenanthrenequinone hybrid molecules and biological evaluation against colon cancer cells as selective Akt kinase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yinfeng Guo Research Topics

Disease

6	Diabetic Nephropathies (Diabetic Nephropathy) 11/2020 - 10/2014
5	Neoplasms (Cancer) 06/2022 - 01/2021
2	Proteinuria 11/2020 - 01/2015
1	Colonic Neoplasms (Colon Cancer) 06/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Triple Negative Breast Neoplasms 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Inflammation (Inflammations) 01/2020
1	Albuminuria 01/2015

Drug/Important Bio-Agent (IBA)

3	Calcitriol (Calcijex)FDA LinkGeneric 11/2020 - 10/2014
3	Vitamin D FDA LinkGeneric 01/2019 - 01/2015
2	Biological ProductsIBA 06/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
2	ascochlorinIBA 01/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 08/2017
1	Phosphotransferases (Kinase)IBA 06/2022
1	9,10-phenanthrenequinoneIBA 06/2022
1	IsatinIBA 06/2022
1	succinimideIBA 06/2022
1	azalomycin F4aIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Androgen Receptor AntagonistsIBA 01/2021
1	pyrimidineIBA 01/2021
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2021
1	enzalutamideIBA 01/2021
1	Dihydroorotate DehydrogenaseIBA 01/2021
1	Purinergic P2X7 ReceptorsIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2018
1	TRPC6 Cation ChannelIBA 01/2015

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022
1	Immunotherapy 01/2022
1	Therapeutics 01/2022
1	Castration 01/2021